NCT03689712 2023-10-24
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients
Galera Therapeutics, Inc.
Phase 3 Completed
Galera Therapeutics, Inc.
Soligenix
University of California, San Francisco
Medical College of Wisconsin
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Instituto Nacional de Cancer, Brazil